Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Nabiximols |
| Trade Name | |
| Synonyms | GW-1000|Sativex|CBD/THC|GW-1000-02 |
| Drug Descriptions |
Nabiximols is a formulation containing tetrahydrocannabinol (THC) and cannabidiol (CBD), along with other cannabinoid and non-cannabinoid components, which potentially increases tumor cell death and enhances antitumor activity (PMID: 25674907, PMID: 33623076). |
| DrugClasses | |
| CAS Registry Number | 56575-23-6 |
| NCIT ID | C71037 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Nabiximols | Nabiximols | 0 | 0 |
| Nabiximols + Temozolomide | Nabiximols Temozolomide | 0 | 1 |